Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

US Bioservices now dispenses CABOMETYX

March 5, 2018

The U.S. Food and Drug Administration has recently approved CABOMETYX (cabozantinib) for the expanded indication of patients with previously untreated advanced renal cell carcinoma (RCC).